TwinBeech Capital’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$702K Buy
+43,595
New +$1M 0.16% 175
2025
Q4
– Sell
-115,341
Closed -$1.46M – 664
2025
Q3
$1.46M Sell
115,341
-81,807
-41% -$933K 0.06% 267
2025
Q2
$1.88M Buy
197,148
+138,623
+237% +$1.53M 0.04% 336
2025
Q1
$612K Buy
+58,525
New +$837K 0.01% 559

Other funds holding DYN

TwinBeech Capital's DYN Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Dyne Therapeutics (DYN) in Q3 2026: 43,595 shares worth $702K. The stake represents 0.16% of the portfolio and ranks #175 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in DYN as recently as Q3 2025.

TwinBeech Capital first reported a position in DYN in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.88M in Q2 2025. 266 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • TwinBeech Capital held 43,595 shares of Dyne Therapeutics worth $702K as of Q3 2026.
  • Dyne Therapeutics was a new TwinBeech Capital position in Q3 2026.
  • Dyne Therapeutics made up 0.16% of TwinBeech Capital's portfolio in Q3 2026, its #175 holding.
  • TwinBeech Capital first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • TwinBeech Capital's Dyne Therapeutics position peaked at $1.88M in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.